Figure 2
From: Dynamic and subtype-specific interactions between tumour burden and prognosis in breast cancer
Adjusted mortality risks according to tumour status (a) and nodal status (b). The relative risk of mortality among 131,178 breast cancer patients was assessed according to different T and N stages of various subtypes when compared with T1 or N0 HR+/HER2− tumours as the reference group. Subgroup analysis of 67,038 patients with tumour diameter ≤ 7 cm in the widest dimension and < 8 metastatic nodes (dotted line area) was performed to determine the degree of prognostic importance as tumours increased in diameter (per cm) or disseminated to one additional axillary lymph node.
